# Effectiveness of Rosuvastatin at Preventing the Progression of Atherosclerosis in HIV Positive Patients

> **NCT00673582** · PHASE4 · TERMINATED · sponsor: **University of British Columbia** · enrollment: 250 (estimated)

## Conditions studied

- Atherosclerosis
- HIV Infections

## Interventions

- **DRUG:** Rosuvastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00673582
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-04
- **Primary completion:** 2012-12
- **Final completion:** 2013-03
- **Target enrollment:** 250 (ESTIMATED)
- **Why stopped:** Sponsor has withdrawn the funding
- **Last updated:** 2009-08-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00673582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00673582, "Effectiveness of Rosuvastatin at Preventing the Progression of Atherosclerosis in HIV Positive Patients". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00673582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*